CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, San Diego |
Catriona Jamieson |
New Faculty II |
Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells |
$3,065,572 |
Stanford University |
Dr. Ching-Pin Chang |
New Faculty II |
VEGF signaling in adventitial stem cells in vascular physiology and disease |
$3,005,695 |
Ludwig Institute for Cancer Research |
Dr. Bing Ren |
New Faculty II |
Mechanisms of chromatin dynamics at enhancers during ES cell differentiation |
$1,726,564 |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
New Faculty II |
Stem Cells in Lung Cancer |
$2,381,572 |
University of California, Davis |
Dr. Paul S. Knoepfler |
New Faculty II |
Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency |
$2,157,255 |
University of California, San Francisco |
Dr. Jeremy Reiter |
New Faculty II |
High throughput modeling of human neurodegenerative diseases in embryonic stem cells |
$2,259,092 |
Gladstone Institutes, J. David |
Dr. Benoit Bruneau |
New Faculty II |
Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors |
$2,723,653 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Zhuohua Zhang |
New Cell Lines |
Derivation of Parkinson’s Disease Coded-Stem Cells (PD-SCs) |
$1,556,448 |
University of California, Los Angeles |
Dr. Jerome A. Zack Ph.D. |
New Cell Lines |
Generation of clinical grade human iPS cells |
$1,341,000 |
Stanford University |
Dr. Renee Reijo Pera PhD |
New Cell Lines |
Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype |
$1,409,243 |
University of Southern California |
Dr. Martin Pera |
New Cell Lines |
New Technology for the Derivation of Human Pluripotent Stem Cell Lines for Clinical Use |
$1,266,134 |
Stanford University |
Michael T. Longaker M.D. |
New Cell Lines |
Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts |
$1,406,636 |
Stanford University |
Dr. Julie Baker |
New Cell Lines |
Derivation of hESC Lines with Disease Lesions |
$1,404,725 |
Scripps Research Institute |
Dr. Sheng Ding Dr. |
New Cell Lines |
Derivation of New ICM-stage hESCs |
$936,973 |
Gladstone Institutes, J. David |
Sheng Ding PhD |
New Cell Lines |
Derivation of New ICM-stage hESCs |
$778,859 |
Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
New Cell Lines |
Induced Pluripotent Stem Cells for Cardiovascular Diagnostics |
$1,708,560 |
Stanford University |
Dr. Michele Calos |
New Cell Lines |
Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses |
$1,406,875 |
University of California, San Francisco |
Dr. Susan J Fisher PhD |
New Cell Lines |
Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines |
$1,383,419 |
University of California, San Francisco |
Dr. Miguel Ramalho-Santos |
New Cell Lines |
Somatic cell age and memory in the generation of iPS cells |
$1,307,201 |
University of California, San Francisco |
Dr. Long-cheng Li |
New Cell Lines |
Induction of pluripotent stem cells by small RNA-guided transcriptional activation |
$1,368,461 |
Gladstone Institutes, J. David |
Robert V Farese |
New Cell Lines |
Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations |
$1,696,424 |
Salk Institute for Biological Studies |
Dr. Fred H Gage |
New Cell Lines |
Development of Induced Pluripotent Stem Cells for Modeling Human Disease |
$1,737,720 |
University of California, Los Angeles |
Dr. Amander Clark Dr. |
New Cell Lines |
Generation of Pluripotent Cell Lines from Human Embryos |
$1,167,416 |
University of California, Irvine |
Dr. Leslie M Thompson |
New Cell Lines |
New Cell Lines for Huntington’s Disease |
$1,302,526 |
University of California, San Diego |
Dr. Steven F Dowdy |
New Cell Lines |
Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin. |
$1,073,585 |
University of California, Davis |
Dr. Mark Zern |
Comprehensive Grant |
An in vitro and in vivo comparison among three different human hepatic stem cell populations. |
$2,251,223 |
Stanford University |
Professor Irving L Weissman MD |
Comprehensive Grant |
Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells |
$2,471,386 |
University of California, San Francisco |
Dr. Andrew D. Leavitt MD |
Comprehensive Grant |
Understanding hESC-based Hematopoiesis for Therapeutic Benefit |
$2,460,822 |
University of California, Irvine |
Dr Hans S Keirstead |
Comprehensive Grant |
hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury |
$2,158,445 |
University of California, Los Angeles |
Dr. Jerome A. Zack Ph.D. |
Comprehensive Grant |
Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease |
$2,401,903 |
University of California, San Diego |
Dr. Yang Xu |
Comprehensive Grant |
Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells |
$2,467,200 |
University of California, Davis |
Dr. Alice F Tarantal |
Comprehensive Grant |
Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells |
$2,166,757 |
Sanford Burnham Prebys Medical Discovery Institute |
Dr. Stuart A Lipton |
Comprehensive Grant |
MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells |
$2,832,000 |
Stanford University |
Dr. Stefan Heller |
Comprehensive Grant |
Generation of inner ear sensory cells from human ES cells toward a cure for deafness |
$2,330,371 |
University of California, Irvine |
Dr. Peter John Donovan |
Comprehensive Grant |
Improved hES Cell Growth and Differentiation |
$2,381,713 |
Children’s Hospital of Los Angeles |
Dr. Gay M. Crooks |
Comprehensive Grant |
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) |
$575,994 |
University of California, Los Angeles |
Dr. Gay Miriam Crooks |
Comprehensive Grant |
Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) |
$1,653,416 |
University of California, San Francisco |
Dr. Samuel Pleasure |
Comprehensive Grant |
Human stem cell derived oligodendrocytes for treatment of stroke and MS |
$2,459,235 |
University of California, San Francisco |
Dr. Harold S Bernstein Dr. |
Comprehensive Grant |
Modeling Myocardial Therapy with Human Embryonic Stem Cells |
$2,134,694 |
Stanford University |
Dr. Roel Nusse |
Comprehensive Grant |
Guiding the developmental program of human embryonic stem cells by isolated Wnt factors |
$1,710,462 |
University of California, Los Angeles |
Dr. Guoping Fan Dr. |
Comprehensive Grant |
Epigenetic gene regulation during the differentiation of human embryonic stem cells: Impact on neural repair |
$2,412,995 |
University of California, San Diego |
Prof. Martin Marsala |
Comprehensive Grant |
Spinal ischemic paraplegia: modulation by human embryonic stem cell implant. |
$2,356,090 |
Gladstone Institutes, J. David |
Dr. Deepak Srivastava |
Comprehensive Grant |
microRNA Regulation of Cardiomyocyte Differentiation from Human Embryonic Stem Cells |
$2,994,719 |
Salk Institute for Biological Studies |
Dr. Fred H Gage |
Comprehensive Grant |
Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons |
$2,749,293 |
Stanford University |
Dr. Renee Reijo Pera PhD |
Comprehensive Grant |
Human oocyte development for genetic, pharmacological and reprogramming applications |
$2,298,411 |
University of California, San Francisco |
Dr. Susan J Fisher PhD |
Comprehensive Grant |
Constructing a fate map of the human embryo |
$2,430,487 |
University of California, Irvine |
Dr. Douglas C. Wallace |
Comprehensive Grant |
The Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning |
$1,790,133 |
University of California, San Francisco |
Dr. Arnold Kriegstein MD, PhD |
Comprehensive Grant |
Derivation of Inhibitory Nerve Cells from Human Embryonic Stem Cells |
$2,410,874 |
Stanford University |
Dr. Christopher K. Zarins |
Comprehensive Grant |
Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells |
$2,454,490 |
Stanford University |
Dr. Theo D. Palmer PhD |
Comprehensive Grant |
Immunology of neural stem cell fate and function |
$2,396,000 |